[mHSPC-Therapie mit Apalutamid/ADT]

Oncol Res Treat. 2020:43 Suppl 2:6-12. doi: 10.1159/000507054. Epub 2020 May 20.
[Article in German]
No abstract available

Keywords: Apalutamid; Prostatakarzinom; Resistenz; TITAN; mHSPC.

Publication types

  • Review

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Docetaxel / adverse effects
  • Docetaxel / therapeutic use
  • Humans
  • Male
  • Neoplasm Metastasis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Thiohydantoins / therapeutic use*

Substances

  • Androgen Antagonists
  • Thiohydantoins
  • apalutamide
  • Docetaxel